MR1 and leukemia: Crowther et al. demonstrated that a human T cell clone potentially recognizes a specific cancer or associated metabolite, restricted to MR1, and mediates the lysis of different types of cancer cells, including leukemic cell lineages; as such, the human T cell clone mediated in vivo leukemia regression and conferred longer survival in mice (99, 100).